135 related articles for article (PubMed ID: 9563667)
1. p53 protein expression in tumours from head and neck subsites, larynx and hypopharynx, and differences in relationship to survival.
Rowley H; Roland NJ; Helliwell TR; Caslin A; Kinsella AR; Jones AS
Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):57-62. PubMed ID: 9563667
[TBL] [Abstract][Full Text] [Related]
2. Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions.
Volavsek M; Bracko M; Gale N
J Laryngol Otol; 2003 Apr; 117(4):286-93. PubMed ID: 12816218
[TBL] [Abstract][Full Text] [Related]
3. [Protein P53 in laryngeal cancer--no evidence of prognostic value].
Woińska-Rojecka T; Chodynicki S; Chyczewski L; Pogumirski J
Otolaryngol Pol; 2001; 55(1):53-6. PubMed ID: 11355478
[TBL] [Abstract][Full Text] [Related]
4. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
5. P53 overexpression in head and neck carcinoma and radiotherapy results.
Awwad S; Jaros E; Somes J; Lunec J
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):323-32. PubMed ID: 8567333
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
7. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.
Spafford MF; Koeppe J; Pan Z; Archer PG; Meyers AD; Franklin WA
Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):627-32. PubMed ID: 8639294
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma.
Klatka J
Eur Arch Otorhinolaryngol; 2001 Dec; 258(10):537-41. PubMed ID: 11829192
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
[TBL] [Abstract][Full Text] [Related]
10. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors.
Nadal A; Campo E; Pinto J; Mallofré C; Palacín A; Arias C; Traserra J; Cardesa A
J Pathol; 1995 Feb; 175(2):181-8. PubMed ID: 7738713
[TBL] [Abstract][Full Text] [Related]
12. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
Franklin S; Pho T; Abreo FW; Nassar R; De Benedetti A; Stucker FJ; Nathan CO
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):177-82. PubMed ID: 10037284
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of EGFR and p53 expression, and angiogenesis in laryngeal squamous cell carcinoma].
Watanabe H; Suzuki T; Ito Y; Mizuta K; Sawai S; Miyata H
Nihon Jibiinkoka Gakkai Kaiho; 1999 Feb; 102(2):243-53. PubMed ID: 10191626
[TBL] [Abstract][Full Text] [Related]
14. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization.
Lukits J; Timár J; Juhász A; Döme B; Paku S; Répássy G
Otolaryngol Head Neck Surg; 2001 Jul; 125(1):18-22. PubMed ID: 11458208
[TBL] [Abstract][Full Text] [Related]
15. BCCIP as a prognostic marker for radiotherapy of laryngeal cancer.
Rewari A; Lu H; Parikh R; Yang Q; Shen Z; Haffty BG
Radiother Oncol; 2009 Feb; 90(2):183-8. PubMed ID: 19046788
[TBL] [Abstract][Full Text] [Related]
16. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
Esser D; Anke S; Roessner A; Freigang B
Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck.
Lavieille JP; Brambilla E; Riva-Lavieille C; Reyt E; Charachon R; Brambilla C
Acta Otolaryngol; 1995 Mar; 115(2):334-9. PubMed ID: 7610836
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of histone demethylase PHF8 associates with adverse prognosis in patients of laryngeal and hypopharyngeal squamous cell carcinoma.
Zhu G; Liu L; She L; Tan H; Wei M; Chen C; Su Z; Huang D; Tian Y; Qiu Y; Liu Y; Zhang X
Epigenomics; 2015; 7(2):143-53. PubMed ID: 25496457
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus and p53 oncoprotein in verrucous carcinoma of the larynx.
López-Amado M; García-Caballero T; Lozano-Ramírez A; Labella-Caballero T
J Laryngol Otol; 1996 Aug; 110(8):742-7. PubMed ID: 8869607
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.
Salerno G; Di Vizio D; Staibano S; Mottola G; Quaremba G; Mascolo M; Galli V; De Rosa G; Insabato L
BMC Cancer; 2006 Jun; 6():146. PubMed ID: 16740156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
